Corporate_Investor_Kineticos Disruptor Fund

Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.

Corporate_Investor_NSW Health

NSW Health provides the tools that translate research into innovative policy and practice for researchers, clinicians, managers and policy makers.

Corporate_Investor_Camtech

Point of care diagnostics and Research & Development as well as manufacturing.

Corporate_Investor_Global Environment Facility

Corporate_Investor_University of Nebraska Medical Center

In addition to providing training for today’s leading medical and healthcare fields, University of Nebraska Medical Center (UNMC) is at the forefront of major research activities.

Corporate_Investor_The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NICHD is a health care company that conducts and supports research to improve the health of children, adults, families, and communities.

Corporate_Investor_Innovation Fund Northeast Ohio

The Innovation Fund, founded by the Lorain County Community College Foundation in 2007, is Northeast Ohio’s most active pre-seed funding for technology startups.

Corporate_Investor_National Institute of Neurological Disorders and Stroke

Corporate_Investor_Center for Innovative Technology

In 2005, CIT celebrated 20 years of creating technology-based companies and strategies for innovation.

Corporate_Investor_MEDTEQ+

MEDTEQ is a non-profit organization for industrial research and innovation in medical technology.